Cas no 1159511-24-6 (1-(1-methylindazol-5-yl)ethanone)
1-(1-methylindazol-5-yl)ethanone Chemical and Physical Properties
Names and Identifiers
-
- 1-(1-Methyl-1H-indazol-5-yl)ethanone
- 1-(1-methylindazol-5-yl)ethanone
- 5-Acetyl-1-methyl-1H-indazole
- 1-(1-Methyl-1H-indazol-5-yl)ethan-1-one
- Ethanone, 1-(1-methyl-1H-indazol-5-yl)-
- NDQKQWAVLOAVRY-UHFFFAOYSA-N
- OR30889
- FCH1134237
- 1-(1-Methyl-1H-indazol-5-yl)-ethanone
- AX8236394
- Y5209
- 1-(1-Methyl-1H-indazol-5-yl)ethan-1-one, AldrichCPR
- DTXSID70653461
- EN300-7378265
- AKOS016004637
- AB90150
- Z1255357259
- CS-0044886
- MFCD11869767
- PS-4806
- SCHEMBL4410330
- 1159511-24-6
- DB-353803
-
- MDL: MFCD11869767
- Inchi: 1S/C10H10N2O/c1-7(13)8-3-4-10-9(5-8)6-11-12(10)2/h3-6H,1-2H3
- InChI Key: NDQKQWAVLOAVRY-UHFFFAOYSA-N
- SMILES: O=C(C)C1C=CC2=C(C=NN2C)C=1
Computed Properties
- Exact Mass: 174.079312947g/mol
- Monoisotopic Mass: 174.079312947g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 217
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 34.9
- XLogP3: 1.3
Experimental Properties
- Boiling Point: 313.1±15.0°C at 760 mmHg
1-(1-methylindazol-5-yl)ethanone Security Information
- Signal Word:Warning
- Hazard Statement: H302
- Warning Statement: P280-P305+P351+P338
- Storage Condition:Sealed in dry,Room Temperature
1-(1-methylindazol-5-yl)ethanone Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | H825646-250mg |
1-(1-methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | ≥95% | 250mg |
1,755.00 | 2021-05-17 | |
| Fluorochem | 228295-250mg |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 95% | 250mg |
£183.00 | 2022-02-28 | |
| Fluorochem | 228295-1g |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 95% | 1g |
£459.00 | 2022-02-28 | |
| Fluorochem | 228295-5g |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 95% | 5g |
£1320.00 | 2022-02-28 | |
| TRC | M322268-5mg |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 5mg |
$ 50.00 | 2022-06-04 | ||
| TRC | M322268-10mg |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 10mg |
$ 70.00 | 2022-06-04 | ||
| TRC | M322268-50mg |
1-(1-Methyl-1H-indazol-5-yl)ethanone |
1159511-24-6 | 50mg |
$ 275.00 | 2022-06-04 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | M79870-250mg |
1-(1-Methyl-1H-indazol-5-yl)ethan-1-one |
1159511-24-6 | 250mg |
¥1396.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | M79870-100mg |
1-(1-Methyl-1H-indazol-5-yl)ethan-1-one |
1159511-24-6 | 100mg |
¥796.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | M79870-1g |
1-(1-Methyl-1H-indazol-5-yl)ethan-1-one |
1159511-24-6 | 1g |
¥4196.0 | 2021-09-08 |
1-(1-methylindazol-5-yl)ethanone Related Literature
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
Additional information on 1-(1-methylindazol-5-yl)ethanone
Comprehensive Overview of 1-(1-Methylindazol-5-yl)ethanone (CAS No. 1159511-24-6): Properties, Applications, and Market Insights
1-(1-Methylindazol-5-yl)ethanone (CAS No. 1159511-24-6) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural properties. This compound, belonging to the indazole derivatives family, features a methyl-substituted indazole core coupled with an acetyl functional group. Its molecular formula is C10H10N2O, and it exhibits a molecular weight of 174.20 g/mol. Researchers are particularly interested in its potential as a pharmacophore in drug discovery, given its ability to interact with biological targets.
The synthesis of 1-(1-Methylindazol-5-yl)ethanone typically involves multi-step organic reactions, including Friedel-Crafts acylation and heterocyclic ring formation. Its purity and stability make it suitable for high-performance liquid chromatography (HPLC) analysis and other advanced analytical techniques. The compound's melting point and solubility profile are critical for its application in formulation studies, especially in the development of bioactive molecules.
In recent years, the demand for indazole-based compounds like 1-(1-Methylindazol-5-yl)ethanone has surged, driven by their role in kinase inhibition and cancer therapeutics. This aligns with the growing focus on targeted drug delivery systems and precision medicine, which are among the top-searched topics in pharmaceutical research. The compound's potential to modulate enzyme activity and cell signaling pathways has also made it a subject of interest in neurodegenerative disease studies.
From an industrial perspective, 1-(1-Methylindazol-5-yl)ethanone is utilized in the synthesis of high-value intermediates for APIs (Active Pharmaceutical Ingredients). Its compatibility with green chemistry principles is another highlight, as manufacturers seek sustainable alternatives to traditional synthetic methods. This trend resonates with the increasing global emphasis on environmentally friendly chemical processes, a frequently searched topic in academic and industrial circles.
The market for 1-(1-Methylindazol-5-yl)ethanone is projected to expand, particularly in regions with robust pharmaceutical R&D infrastructure, such as North America, Europe, and Asia-Pacific. Key players are investing in scalable synthesis routes to meet the rising demand from contract research organizations (CROs) and biotech startups. Additionally, the compound's relevance in computational chemistry and molecular docking studies has further amplified its commercial appeal.
For researchers exploring structure-activity relationships (SAR), 1-(1-Methylindazol-5-yl)ethanone serves as a versatile scaffold. Its electron-rich aromatic system allows for diverse functionalization, enabling the design of novel small-molecule inhibitors. This adaptability is crucial in addressing challenges like drug resistance, a hot topic in contemporary medicinal chemistry.
In summary, 1-(1-Methylindazol-5-yl)ethanone (CAS No. 1159511-24-6) represents a promising candidate for advancing drug discovery and material science. Its multifaceted applications, coupled with the industry's shift toward sustainable synthesis, position it as a compound of enduring relevance. As scientific inquiries into indazole derivatives continue to evolve, this compound is poised to play a pivotal role in shaping future innovations.
1159511-24-6 (1-(1-methylindazol-5-yl)ethanone) Related Products
- 1001906-63-3(1-(1H-indazol-5-yl)ethan-1-one)
- 1159511-29-1(1-(2-methyl-2H-indazol-6-yl)ethan-1-one)
- 1159511-26-8(1-(1-Methyl-1H-indazol-7-yl)ethanone)
- 1159511-25-7(1-(1-Methyl-1H-indazol-6-yl)ethanone)
- 1053655-56-3(1-Methyl-1H-indazole-4-carbaldehyde)
- 951030-58-3(1-Methyl-1H-indazole-7-carbaldehyde)
- 872607-89-1(1-Methyl-1H-indazole-5-carbaldehyde)
- 1159511-23-5(4-Acetyl-1-methyl-1H-indazole)
- 1130309-67-9(5-(2-Aminoethyl)-1-methyl-1H-indazole)
- 1092351-51-3(1-Methyl-1H-indazole-6-carbaldehyde)